Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefits of Extracorporeal Shockwave Therapy to Reduce Spasticity in Stroke/CP

NCT06548321 is registered in ClinicalTrials.gov with Superior University as lead sponsor.

NCT NCT06548321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06548321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefits of Extracorporeal Shockwave Therapy to Reduce Spasticity in Stroke/CP
Lead sponsor
Superior University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 1, 2023
Completion date
September 30, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, cerebral